This adaptive dosing program is designed to find the ideal dose for each individual, minimizing unnecessary drug exposure and side effects
Tests in obese mice indicated the triple agonist was more powerful than dual agonists in correcting obesity and diabetes (Finan, Yang, Ottaway)
"We've obviously been working in this category of medicines for a while with the first GLP-1 medication 20 years ago and improving ever since
A clinician may need to consider the wider health picture instead of assuming the medication is the sole cause
Written by Jordan Caulfield & medically reviewed by Dr Lilla Csonka: : June 06, 2026 GLP-1 has quickly become one of the most discussed topics in weight management and metabolic health
Metabolic syndrome is a cluster of conditions-increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels-that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes
